Equity Research
William Blair research analyst Sami Corwin was quoted in MedCity News following the acquisition of Legend Biotech by Novartis, a move focused on cell therapy for solid tumors.
“The deal is an ‘incremental positive’ for Legend, allowing the company to monetize its DLL3 program earlier in development,” Corwin wrote in the note to investors that was quoted by the publication.
Stay up-to-date with the latest William Blair news and insights
Jed Dorsheimer welcomes Doomberg for an in-depth discussion on the complexities of renewable energy integration and its impact on grid efficiency, exploring the challenges posed by the variability of renewables, the resurgence of nuclear power, and the critical role of natural gas in bridging the energy transition.
William Blair, the premier global boutique with expertise in investment banking, investment management, and private wealth management, is thrilled to announce its performance in the annual Coalition Greenwich Voice of the Client – 2024 North American Equity Investors Study.
William Blair Investment Management portfolio manager Marcelo Assalin was published in Germany’s IPE D.A.C.H., where he shared his team’s outlook on emerging market debt investments following the election of Donald Trump.
Information contained on the internet is not subject to William Blair & Company's control or review, and may not be accurate.
For disclosure information, please visit www.williamblair.com/disclosures
